ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,249.66
0.00%
Dow Jones
42,706.56
-0.06%
Gold vs US Dollar
2,639.815
0.19%
Brent Oil
75.895
-0.29%
Bitcoin
101,733.39
-0.54%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. KALA BIO Inc (KALA)

  7. KALA BIO Inc (KALA) News

KALA BIO (KALA)

KALA BIO Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KALA
DateTimeSourceHeadlineSymbolCompany
03/01/202512:07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KALAKALA BIO Inc
31/12/202421:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:KALAKALA BIO Inc
30/12/202414:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
30/12/202413:00GlobeNewswire Inc.KALA BIO Announces $10,750,000 Private PlacementNASDAQ:KALAKALA BIO Inc
27/11/202413:00GlobeNewswire Inc.KALA BIO to Present at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
14/11/202421:49Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KALAKALA BIO Inc
12/11/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
12/11/202413:00GlobeNewswire Inc.KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
25/09/202420:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
06/09/202420:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:KALAKALA BIO Inc
08/08/202412:00GlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:KALAKALA BIO Inc
06/08/202412:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
06/08/202412:00GlobeNewswire Inc.KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
01/08/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KALAKALA BIO Inc
31/07/202420:08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KALAKALA BIO Inc
25/07/202420:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KALAKALA BIO Inc
17/07/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
16/07/202421:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
09/07/202400:54Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:KALAKALA BIO Inc
27/06/202412:00GlobeNewswire Inc.KALA BIO Announces $12,500,000 Private PlacementNASDAQ:KALAKALA BIO Inc
13/06/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
13/06/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
13/06/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
12/06/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
04/06/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
04/06/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
04/06/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
30/05/202420:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KALAKALA BIO Inc
29/05/202412:00GlobeNewswire Inc.KALA BIO to Present at Jefferies Global Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
14/05/202420:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
 Showing the most relevant articles for your search:NASDAQ:KALA

Your Recent History

BIT
UC7C74
Unicredit Bank
BIT
I06747
Intesa Sanpaolo
BIT
UC6TGV
Unicredit Bank
BIT
I07247
INTESA SANPAOLO
UNSW3
HTBETH
Hotbit Token
TG
M5Z
Manz Automation Ag Npv
BIT
UC466K
Unicredit Bank
BIT
UC7C5Y
Unicredit Bank
BIT
UV8BLL
UniCredit Bank
BIT
UB3YGP
Unicredit Bank
BIT
UC7F6Y
Unicredit Bank
BIT
UB87R9
Unicredit Bank
BOV
GOAU4
GERDAU MET PN
BIT
UC65M4
Unicredit Bank
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads